Family Caregivers in Underserved Populations Providing Complex Cancer Care
3 other identifiers
interventional
48
1 country
1
Brief Summary
This clinical trial develops and tests a model of family caregiver education focused on the role of underserved family caregivers as providers of complex care in the home. Cancer patients have symptoms from their cancer or treatment and are then supported by family caregivers at home with tasks requiring technical skill. Family caregivers are often asked to provide complex care whether it involves decisions about managing symptoms or providing technical care for ports/pumps, tubes, or devices. Family caregivers often are not given enough information on how to provide care for patients at home needing complex care. The results from this study may help researchers refine and improve the intervention for caregivers through future research for caregivers on a much larger scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2020
CompletedFirst Submitted
Initial submission to the registry
December 10, 2020
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2022
CompletedJanuary 5, 2024
January 1, 2024
1.6 years
December 10, 2020
January 2, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Family caregiver distress scale
Descriptive statistics will be used to summarize the distress scale. Analysis of variance (ANOVA) will be used to compare scores at the three points of baseline, 3 weeks, and 7 weeks.
up to 7 weeks
Change in Quality of life (QOL) scale
Descriptive statistics will be used to summarize the Caregiver QOL scale. ANOVA will be used to compare scores at the three points of baseline, 3 weeks, and 7 weeks.
Up to 7 weeks
Study Arms (1)
Supportive Care (teaching intervention, questionnaire)
EXPERIMENTALParticipants attend 2 teaching sessions with a research nurse. Participants also complete questionnaires at baseline, 3, and 7 weeks.
Interventions
Receive teaching intervention
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- PATIENT: Diagnosis of any stage lung or gynecologic (gyn) cancer
- PATIENT: Read and understand English
- PATIENT: Requires either complex physical care or complex decision making regarding symptoms
- PATIENT: Age 18 years or older
- FCG: Designated by the patient as their caregiver
- FCG: Read and understand English
- FCG: Age 18 years or older
- FCG: Providing complex care and/or complex decision-making
You may not qualify if:
- Inability to read and understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
City of Hope Medical Center
Duarte, California, 91010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Betty Ferrell
City of Hope Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2020
First Posted
January 28, 2022
Study Start
July 15, 2020
Primary Completion
March 9, 2022
Study Completion
March 9, 2022
Last Updated
January 5, 2024
Record last verified: 2024-01